Inadequate copper intake reduces serum insulin-like growth factor-I and bone strength in growing rats fed graded amounts of copper and zinc

被引:52
作者
Roughead, ZK [1 ]
Lukaski, HC [1 ]
机构
[1] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA
关键词
copper; zinc; bone strength; IGF-I; osteoporosis;
D O I
10.1093/jn/133.2.442
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This study examined the effects of graded intakes of zinc (Zn) and copper (Cu) on serum insulin-like growth-factor-I (IGF-I) concentration and bone quality in growing rats. Using a 3 X 4 factorial design, weanling male Sprague-Dawley rats were randomly assigned to 12 groups (n = 7 per group) and were fed one of nine modified AIN-93G basal diets with varying amounts of Cu (0.3, 3 and 10 mug/g) and Zn (5, 15 and 45 mug/g) for 6 wk. A group of rats was pair-fed to each low Zn group. Although dietary Zn mainly influenced body weights (P < 0.0001), dietary Cu was the main determinant of most of the variables related to bone quality. Low Cu intake reduced serum IGF-I and femur breaking force and ultimate stress (by 27, 14 and 7%, respectively; P < 0.05) and increased bone IGF-I concentration (by 62%; P < 0.0001). Low Cu intake also increased femur nitrogen, hydroxyproline, hexosamine and calcium (Ca) concentrations of long bones (P < 0.05). Lumbar vertebrae dry weight and density were the lowest in the rats fed the low Cu diets (P < 0.001) and were higher in the rats fed high amounts of both Cu and Zn (P < 0.01). In summary, growing rats fed low and marginal Cu had lower serum IGF-I than those fed high dietary Cu. Bone strength was also reduced with low dietary Cu, despite compensatory changes in the bone matrix. In the presence of graded intakes of Cu, the effects of low dietary Zn were more pronounced on the spinal bones than the long bones.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 38 条
[1]   MECHANICAL-PROPERTIES, BONE-MINERAL CONTENT, AND BONE-COMPOSITION (COLLAGEN, OSTEOCALCIN, IGF-I) OF THE RAT FEMUR - INFLUENCE OF OVARIECTOMY AND NANDROLONE DECANOATE (ANABOLIC-STEROID) TREATMENT [J].
AERSSENS, J ;
VANAUDEKERCKE, R ;
GEUSENS, P ;
SCHOT, LPC ;
OSMAN, AAH ;
DEQUEKER, J .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (04) :269-277
[2]  
Bergman I, 1970, Clin Chim Acta, V27, P347, DOI 10.1016/0009-8981(70)90355-4
[3]   Insulin-like growth factors and osteoporosis [J].
Canalis, E .
BONE, 1997, 21 (03) :215-216
[4]   Failure of IGF-I infusion to promote growth in Zn deficient hypophysectomized rats [J].
Cha, MC ;
Rojhani, A .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 1998, 12 (03) :141-147
[5]   INSULIN-LIKE GROWTH FACTOR-I HORMONAL-REGULATION BY GROWTH-HORMONE AND BY 1,25(OH)2D3 AND ACTIVITY ON HUMAN OSTEOBLAST-LIKE CELLS IN SHORT-TERM CULTURES [J].
CHENU, C ;
VALENTINOPRAN, A ;
CHAVASSIEUX, P ;
SAEZ, S ;
MEUNIER, PJ ;
DELMAS, PD .
BONE, 1990, 11 (02) :81-86
[6]  
Danks D M, 1980, Ciba Found Symp, V79, P209
[7]  
Davis G K, 1980, Ann N Y Acad Sci, V355, P130, DOI 10.1111/j.1749-6632.1980.tb21333.x
[8]   Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women [J].
Devine, A ;
Rosen, C ;
Mohan, S ;
Baylink, D ;
Prince, RL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (01) :200-206
[9]   Nutrition and the insulin-like growth factor system [J].
Estivariz, CF ;
Ziegler, TR .
ENDOCRINE, 1997, 7 (01) :65-71
[10]  
FARQUHARSON C, 1989, P SOC EXP BIOL MED, V192, P166, DOI 10.3181/00379727-192-42973